GTx, Inc. Presents On Enobosarm As Targeted Therapy For The Treatment Of Androgen Receptor-Positive Breast Cancer At The San Antonio Breast Cancer Symposium

GTx, Inc. (Nasdaq: GTXI) announced today a scientific presentation will be made at the 2013 San Antonio Breast Cancer Symposium, December 10-14, 2013, in San Antonio, Texas, involving technology licensed from the University of Tennessee Research Foundation and developed by the Company.

Help employers find you! Check out all the jobs and post your resume.